A Longitudinal Observational Study of the Natural History and Management of Patients With HCC

Active:	Yes
Cancer Type:	Liver Cancer / Hepatoblastoma	NCT ID:	NCT02954094
Trial Phases:		Protocol IDs:	TARGET-HCC (primary) NCI-2018-00316
Eligibility:	18 Years and older, Male and Female	Study Type:	Other
Study Sponsor:	Target PharmaSolutions, Inc.
NCI Full Details:	http://clinicaltrials.gov/show/NCT02954094

Summary

TARGET-HCC is a longitudinal, observational study of patients being managed for HCC in usual
clinical practice. TARGET-HCC will create a research registry of participants with HCC within
academic and community real-world practices in order to assess the safety and effectiveness
of the entire spectrum of current and future therapies across diverse populations.

Treatment Sites in Georgia

Emory University Hospital - Atlanta
1364 Clifton Road NE
Atlanta, GA 30322
www.emoryhealthcare.org

Piedmont Hospital - Atlanta
1968 Peachtree Road, NW
Atlanta, GA 30309
www.piedmont.org

**Clinical trials are research studies that involve people. These studies test new ways to prevent, detect, diagnose, or treat diseases. People who take part in cancer clinical trials have an opportunity to contribute to scientists’ knowledge about cancer and to help in the development of improved cancer treatments. They also receive state-of-the-art care from cancer experts... Click here to learn more about clinical trials.